Novavax says COVID-19 vaccine candidate shows immune response against Beta variant

0
27

Article content

Novavax Inc said on Friday its

COVID-19 vaccine candidate showed immune response and protection

against the SARS-CoV-2 Beta variant, which was originally

identified in South Africa, in three animal and human studies.

(Reporting by Mrinalika Roy in Bengaluru; Editing by Shinjini

Ganguli)